NEW ACTIVITY! This game-based educational activity examines how obesity affects the body, dispels common obesity and treatment myths, and explores the social impact of obesity on the patient and their social network. Scan QR code or visit Link in our bio! paradigmmed.org/1371-2

FREE NEW CME! This webinar will present new guideline recommendations for the treatment of LN along with recently published data from the phase 3 REGENCY trial of the novel B-cell–depleting agent obinutuzumab in LN. Scan QR code or visit link in bio! paradigmmed.org/1361-2

[1373-1] FREE NEW CME! Enhance your expertise in managing patients with age-related macular degeneration through this engaging activity that highlights key data on novel and emerging sustained delivery therapies, as well as optimal treatment strategies. paradigmmed.org/1373-1

STILL HAVE TIME TO REGISTER! FREE NEW CME! LIVE/LIVE STREAMING SYMPOSIUM Diverse Applications of Sustained Delivery Therapy in Retinal Vascular Diseases Scan the CODE or LINK in our Bio

"LAST CHANCE" FREE CME! Recent developments in the treatment of melanoma highlight the role of immune checkpoint inhibitors for early and advanced disease. Join this engaging case-based review of current treatments, and learn about emerging treatments. paradigmmed.org/1283

"FEATURED CME" FREE CME! IBD experts discuss recent developments in managing and monitoring patients with IBD in a roundtable conversation. They add context to the cases to examine management of IBD in the context of comorbid conditions, and contraindications to therapies.

"FEATURED CME" FREE CME! Get answers to frequently asked questions about the FDA-approved port delivery system and other promising sustained delivery therapies (ie, tyrosine kinase inhibitors and gene therapies) in this fast-paced, expert-led, Q&A-based activity. Link in bio

"FEATURED CME" FREE CME! Join our expert faculty as they discuss current and novel treatments for IDH-mutated AML. This engaging roundtable will focus on the development of targeted agents for treatment and the optimal sequencing of therapies. paradigmmed.org/1342

"FEATURED CME" FREE CME! View a case-based presentation focused on the role of TYK2 inhibition in psoriasis, highlighting the unique MOA and key data to inform clinical use with expert commentary from the faculty presenter. Link in bio or Scan QR code paradigmmed.org/1284-6

"FEATURED CME" FREE CME! View this whiteboard animation-enhanced activity demonstrating the evolution and practical uses of sustained delivery therapy, with videos and case studies featuring the recently approved ranibizumab port delivery system. paradigmmed.org/1221

"FEATURED CME" FREE CME! Join this engaging tumor-board style discussion of CLL/SLL patient cases that include cytogenetic and molecular testing, and strategize how to successfully navigate the challenges with initial and R/R treatment selection. paradigmmed.org/1289-3

"FEATURED CME" FREE CME! paradigmmed.org/1233-1

"FEATURED CME" FREE CME! Join this engaging discussion about treatment selection and sequencing in patients with RRMM, which will highlight CAR T-cell therapy and bispecific agents. Link in bio or Scan QR code paradigmmed.org/13002

"FEATURED CME" FREE CME! Novel retinal therapies reduce treatment burden versus the standard of care—but is that where the similarities end? Find out in this nuanced, expert-led discussion of the latest evidence—View Now! Link in bio or Scan QR code paradigmmed.org/1312

"FEATURED CME" FREE CME! Durability is just the tip of the iceberg with second-generation therapy. Dive deep into treatment and (and retreatment) considerations in this practical and engaging point-counterpoint activity. Link in Bio or SCAN QR code paradigmmed.org/1309

FREE CME! On-Demand Webinar: "A Treatment-Naïve Patient With PDR and DME". Link in our Bio or Scan QR code bit.ly/a1327-4

"FEATURED" FREE CME! This activity explores HER2 overexpression in NSCLC, testing, and HER2-targeted ADCs. Learn to navigate therapy selection and align care with current guidelines to enhance patient outcomes. Link in bio or Scan QR code paradigmmed.org/1383

FREE NEW CME! How do you manage new-onset exudative macular degeneration with subretinal hemorrhage and a large pigment epithelial detachment requiring prompt treatment? paradigmmed.org/1345five

"EXPIRING SOON!" FREE CME! Explore a case simulation highlighting how social and healthcare disparities impact glaucoma outcomes. Learn to apply evidence-based, equitable care with expert insights. LINK IN BIO paradigmmed.org/1233-3

NEW! Free CME! Starting new anti-VEGF therapies can be challenging. Do you need all the loading doses, or can you start extending once the retinal fluid has been reduced? paradigmmed.org/1345-4